Funded Research
Since 2010, the Snowdome Foundation has enabled more than $95 million to be invested in cutting-edge blood cancer research.
This funding has supported 84 research projects and facilitated the creation of over 105 research positions.
Snowdome is the leading not-for-profit focused exclusively on translational research, where scientific findings are used to
advance the development of innovative diagnostic tools and treatments. We have a keen interest in research
that accelerates next-generation treatments and advances precision therapy including genomic testing,
targeted therapies and immune therapies. We fund both research and clinical trials.
Grants
Through the incredible generosity of our philanthropic donors and partners, the Snowdome Foundation can provide Australia’s best clinicians and researchers with much-needed funding to support their work.
To view current grant calls, click here.
In 2025, Snowdome awarded the following grants to exceptional researchers pursuing innovative approaches to blood cancer research and treatments.
- Dr Criselle D’Souza: Developing a new cellular immunotherapy for T cell lymphoma
- Prof. Mark Dawson: Klempfner Snowdome Fellowship
- Dr Brian Grainger: GURNER™ Snowdome Immunotherapy Fellowship
- Dr Paniz Tavakoli: Cannon Family Travel Grant
- Dr Helen Cashman: Cannon Family Travel Grant
